Why the study?
Does race affect long-term mortality in patients receiving preoperative inotropic agents prior to CABG?
Does race affect long-term mortality in patients receiving preoperative inotropic agents prior to CABG?
Black patients receiving preoperative inotropic agents before CABG have a significantly higher risk of long-term mortality compared to White patients, representing an independent preoperative risk factor.
Higher mortality with preoperative inotropes in Black versus White CABG patients; hypothesis-generating and requires prospective validation.
The aim of this study was to examine racial differences in long-term mortality after coronary artery bypass grafting (CABG), stratified by preoperative use of inotropic agents. Black and white patients who required preoperative inotropic support prior to undergoing CABG procedures between 1992 and 2011 were compared. Mortality probabilities were computed using the Kaplan-Meier product-limit method. Hazard ratios (HR) and 95% confidence intervals (CI) were computed using a Cox regression model. A total of 15,765 patients underwent CABG, of whom 211 received preoperative inotropic agents within 48 hours of surgery. Long-term mortality differed by race (black versus white) among preoperative inotropic category (inotropes: adjusted HR = 1.6, 95% CI = 1.009-2.4; no inotropes: adjusted HR = 1.15, 95% CI = 1.08-1.2; P(interaction) < 0.0001). Our study identified an independent preoperative risk-factor for long-term mortality among blacks receiving CABG. This outcome provides information that may be useful for surgeons, primary care providers, and their patients.
No takes yet. Share an insight, caveat, or question.
Efird et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: